A complex role for complement in allergic asthma
- PMID: 20402389
- PMCID: PMC2856962
- DOI: 10.1586/eci.09.84
A complex role for complement in allergic asthma
Abstract
Allergic asthma is a chronic inflammatory disease of the upper airway. It is well appreciated that maladaptive Th2 immunity promotes the allergic phenotype, the underlying mechanisms of which remain elusive. The disease is associated with activation of complement, an ancient danger-sensing component of the innate immune system. Different models of experimental allergic asthma suggest that the small complement fragments of C3 and C5, the anaphylatoxins C3a and C5a, not only promote proallergic effector functions during the allergic effector phase but regulate the development of Th2 immunity during allergen sensitization. The available data support a concept in which C5a is dominant during allergen sensitization and protects against the development of maladaptive Th2 immunity. By contrast, C3a and C5a appear to act synergistically and drive allergic inflammation during the effector phase. In this article, we will review the recent findings in the field to judge the benefit of complement targeting in allergic asthma.
Keywords: Th2 cytokine; allergic asthma; anaphylatoxin; complement; dendritic cell; innate immunity.
Conflict of interest statement
This work has been supported by NIH grant AI057839 and DFG Transregio 22 project A21 to Jörg Köhl. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Figures


Similar articles
-
The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma.Mol Immunol. 2004 Jun;41(2-3):123-31. doi: 10.1016/j.molimm.2004.03.019. Mol Immunol. 2004. PMID: 15159057 Review.
-
Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.J Immunol. 2014 Dec 1;193(11):5387-401. doi: 10.4049/jimmunol.1400080. Epub 2014 Oct 29. J Immunol. 2014. PMID: 25355927
-
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma.J Clin Invest. 2006 Mar;116(3):783-96. doi: 10.1172/JCI26582. J Clin Invest. 2006. PMID: 16511606 Free PMC article.
-
Anaphylatoxins coordinate innate and adaptive immune responses in allergic asthma.Semin Immunol. 2013 Feb;25(1):2-11. doi: 10.1016/j.smim.2013.04.009. Epub 2013 May 19. Semin Immunol. 2013. PMID: 23694705 Review.
-
Regulation and function of anaphylatoxins and their receptors in allergic asthma.Mol Immunol. 2017 Apr;84:51-56. doi: 10.1016/j.molimm.2016.11.013. Mol Immunol. 2017. PMID: 27916272 Review.
Cited by
-
A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.PLoS One. 2012;7(11):e50327. doi: 10.1371/journal.pone.0050327. Epub 2012 Nov 26. PLoS One. 2012. PMID: 23189195 Free PMC article.
-
Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy.Int J Mol Sci. 2022 Nov 18;23(22):14340. doi: 10.3390/ijms232214340. Int J Mol Sci. 2022. PMID: 36430817 Free PMC article. Review.
-
Complement system in lung disease.Am J Respir Cell Mol Biol. 2014 Oct;51(4):467-73. doi: 10.1165/rcmb.2013-0485TR. Am J Respir Cell Mol Biol. 2014. PMID: 24901241 Free PMC article. Review.
-
Complement, a target for therapy in inflammatory and degenerative diseases.Nat Rev Drug Discov. 2015 Dec;14(12):857-77. doi: 10.1038/nrd4657. Epub 2015 Oct 23. Nat Rev Drug Discov. 2015. PMID: 26493766 Free PMC article. Review.
-
Single-cell RNA sequencing reveals transcriptional changes in circulating immune cells from patients with severe asthma induced by biologics.Exp Mol Med. 2024 Dec;56(12):2755-2762. doi: 10.1038/s12276-024-01368-y. Epub 2024 Dec 13. Exp Mol Med. 2024. PMID: 39672815 Free PMC article.
References
-
- Köhl J, Wills-Karp M. Complement regulates inhalation tolerance at the dendritic cell/T cell interface. Mol. Immunol. 2007;44(1–3):44–56. - PubMed
-
- Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 1999;17(9):255–281. - PubMed
-
- Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 2002;3(8):715–720. - PubMed
-
- Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol. Rev. 2004;202:175–190. - PubMed
-
- Wills-Karp M, Koehl J. New insights into the role of the complement pathway in allergy and asthma. Curr. Allergy Asthma Rep. 2005;5(5):362–369. - PubMed
Website
-
- Neurogen Reports Phase IIa Clinical. www.ctinnovations.com/news/126.php.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous